Expansion of the production capacity of Hiperon Genetics Kft. (Q3916618): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: add summary)
(‎Changed an Item: Adding English translations)
Property / summary
 
1, The biomolecule isolation and discharge system is suitable for isolating DNA and RNA molecules from various biological materials (cell culture, blood, tissue, tissue cultures) and can also be used for plasmid, oligonucleotide, or PCR product purification. After isolation, the system is suitable for quantitative and qualitative analysis of the isolated sample based on two independent methods (amplification and gel electrophoresis). 2,The pipette with automatic microdisk reader is suitable for compiling various enzyme reactions and for quality control of the final product. The sample dispenser is able to use different components (e.g. antibodies, enzymes or other purified proteins, substrates, buffer components) to be softwarely controlled by different volume units, with microlitre precision, into 96-well plates or different reaction tubes. 3, Molecular Biological Software Molecular Biological Software is suitable for the local and internet control of instruments and for the rapid processing of information generated by sensors incorporated into the instruments during production. With the help of molecular biological software, Hiperon Genetics Kft. the production of the product can be documented not only in real time but also retrospectively. By accessing the generated data by cloud access, the user of the product can also have password-protected access. Hiperon Genetics Ltd. is also planning to build a new building to expand its production capacity to a site owned by the company in Szeged in the framework of the present tender. Compliance with assessment criteria: • Established: In 2009, i.e. more than 5 complete financial years • The share of women’s owners in the company is 52 % and Mátyásné Vukosávlyev also holds the position of managing director • Procurement of instruments in the framework of the project is carried out in a free business zone (Mórahalom) • Industrial rights protection: Erika Keresztné, the inventor of several patents, uses the patents during the productive investment on the basis of a contract with the applicant company (Delta Bio 2000 Kft). Delta Bio Kft and HIperon Genetics Kft. have concluded a licence agreement and an economic event has also taken place from this legal transaction in the two years preceding the submission of the grant application, which it can prove by means of an invoice and a bank statement. • Company with high growth potential. net turnover 177 Mft in 2014 and 357 Mft in 2015 • Export-oriented enterprise: In 2016, more than 15 % of turnover came from exports • Quality Management System according to ISO 9001 Standard • The activity to be developed under the project (2110 Pharmaceuticals manufacturing) is one of the sectors to be developed as highlighted in the Irinyi Plan • No irregularities in relation to its previous projects • The company implements IPAR 4.0 in the framework of this project. (English)
Property / summary: 1, The biomolecule isolation and discharge system is suitable for isolating DNA and RNA molecules from various biological materials (cell culture, blood, tissue, tissue cultures) and can also be used for plasmid, oligonucleotide, or PCR product purification. After isolation, the system is suitable for quantitative and qualitative analysis of the isolated sample based on two independent methods (amplification and gel electrophoresis). 2,The pipette with automatic microdisk reader is suitable for compiling various enzyme reactions and for quality control of the final product. The sample dispenser is able to use different components (e.g. antibodies, enzymes or other purified proteins, substrates, buffer components) to be softwarely controlled by different volume units, with microlitre precision, into 96-well plates or different reaction tubes. 3, Molecular Biological Software Molecular Biological Software is suitable for the local and internet control of instruments and for the rapid processing of information generated by sensors incorporated into the instruments during production. With the help of molecular biological software, Hiperon Genetics Kft. the production of the product can be documented not only in real time but also retrospectively. By accessing the generated data by cloud access, the user of the product can also have password-protected access. Hiperon Genetics Ltd. is also planning to build a new building to expand its production capacity to a site owned by the company in Szeged in the framework of the present tender. Compliance with assessment criteria: • Established: In 2009, i.e. more than 5 complete financial years • The share of women’s owners in the company is 52 % and Mátyásné Vukosávlyev also holds the position of managing director • Procurement of instruments in the framework of the project is carried out in a free business zone (Mórahalom) • Industrial rights protection: Erika Keresztné, the inventor of several patents, uses the patents during the productive investment on the basis of a contract with the applicant company (Delta Bio 2000 Kft). Delta Bio Kft and HIperon Genetics Kft. have concluded a licence agreement and an economic event has also taken place from this legal transaction in the two years preceding the submission of the grant application, which it can prove by means of an invoice and a bank statement. • Company with high growth potential. net turnover 177 Mft in 2014 and 357 Mft in 2015 • Export-oriented enterprise: In 2016, more than 15 % of turnover came from exports • Quality Management System according to ISO 9001 Standard • The activity to be developed under the project (2110 Pharmaceuticals manufacturing) is one of the sectors to be developed as highlighted in the Irinyi Plan • No irregularities in relation to its previous projects • The company implements IPAR 4.0 in the framework of this project. (English) / rank
 
Normal rank
Property / summary: 1, The biomolecule isolation and discharge system is suitable for isolating DNA and RNA molecules from various biological materials (cell culture, blood, tissue, tissue cultures) and can also be used for plasmid, oligonucleotide, or PCR product purification. After isolation, the system is suitable for quantitative and qualitative analysis of the isolated sample based on two independent methods (amplification and gel electrophoresis). 2,The pipette with automatic microdisk reader is suitable for compiling various enzyme reactions and for quality control of the final product. The sample dispenser is able to use different components (e.g. antibodies, enzymes or other purified proteins, substrates, buffer components) to be softwarely controlled by different volume units, with microlitre precision, into 96-well plates or different reaction tubes. 3, Molecular Biological Software Molecular Biological Software is suitable for the local and internet control of instruments and for the rapid processing of information generated by sensors incorporated into the instruments during production. With the help of molecular biological software, Hiperon Genetics Kft. the production of the product can be documented not only in real time but also retrospectively. By accessing the generated data by cloud access, the user of the product can also have password-protected access. Hiperon Genetics Ltd. is also planning to build a new building to expand its production capacity to a site owned by the company in Szeged in the framework of the present tender. Compliance with assessment criteria: • Established: In 2009, i.e. more than 5 complete financial years • The share of women’s owners in the company is 52 % and Mátyásné Vukosávlyev also holds the position of managing director • Procurement of instruments in the framework of the project is carried out in a free business zone (Mórahalom) • Industrial rights protection: Erika Keresztné, the inventor of several patents, uses the patents during the productive investment on the basis of a contract with the applicant company (Delta Bio 2000 Kft). Delta Bio Kft and HIperon Genetics Kft. have concluded a licence agreement and an economic event has also taken place from this legal transaction in the two years preceding the submission of the grant application, which it can prove by means of an invoice and a bank statement. • Company with high growth potential. net turnover 177 Mft in 2014 and 357 Mft in 2015 • Export-oriented enterprise: In 2016, more than 15 % of turnover came from exports • Quality Management System according to ISO 9001 Standard • The activity to be developed under the project (2110 Pharmaceuticals manufacturing) is one of the sectors to be developed as highlighted in the Irinyi Plan • No irregularities in relation to its previous projects • The company implements IPAR 4.0 in the framework of this project. (English) / qualifier
 
point in time: 8 February 2022
Timestamp+2022-02-08T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 14:36, 8 February 2022

Project Q3916618 in Hungary
Language Label Description Also known as
English
Expansion of the production capacity of Hiperon Genetics Kft.
Project Q3916618 in Hungary

    Statements

    0 references
    201,806,200 forint
    0 references
    558,036.52 Euro
    0.00276521 Euro
    3 December 2021
    0 references
    1,104,429.619 Euro
    0.0027336256 Euro
    14 December 2021
    0 references
    404,016,416.416 forint
    0 references
    49.95 percent
    0 references
    26 November 2018
    0 references
    29 August 2020
    0 references
    Hiperon Genetics Kutató és Tanácsadó Korlátolt Felelősségű Társaság
    0 references
    0 references

    46°12'37.04"N, 19°53'58.16"E
    0 references
    1, A biomolekula izoláló és kiszerelő rendszer alkalmas különböző biológiai anyagokból (sejttenyészet, vér, szövetek, szövettenyészetek) DNS és RNS molekulák izolálására, és használható plazmid, oligonukleotid, vagy PCR termék tisztításra is. Az izolálás után a rendszer alkalmas az izolált minta kvantitatív és kvalitatív analízisére is két, egymástól független módszer alapján (amplifikálhatóság és gélelektroforézis). 2, A pipettázó automata mikrolemez olvasóval alkalmas különböző enzimreakciók összeállítására és a végtermék minőségi ellenőrzésére. A mintaadagoló különböző komponensekből (pl. ellenanyag, enzim vagy más tisztított fehérje, szubsztrát, pufferkomponensek) képes szoftveresen kontrolálhatóan különböző térfogategységeket, mikroliteres precizitással adagolni 96 lyukú lemezekbe vagy különböző reakció csövekbe. 3, Molekuláris biológiai szoftver A molekuláris biológiai szoftver alkalmas a műszerek helyi illetve interneten keresztül történő vezérlésére és a műszerekbe épített szenzorok által a gyártás során keletkező információk gyors feldolgozására. A molekuláris biológiai szoftver segítségével a Hiperon Genetics Kft. a termék előállítása nemcsak valós időben hanem visszamenőleg is dokumentálható. A keletkezett adatokhoz felhő eléréssel a termék felhasználója számára is jelszóval védett hozzáférés biztosítható. A Hiperon Genetics Kft. új épület építését is tervezi a termelési kapacitásainak bővítéséhez a vállalkozás tulajdonában álló szegedi telephelyre a jelen pályázat keretében. Értékelési szempontok való megfelelés: • Alapítva: 2009-ben, azaz 5-nél több lezárt, teljes üzleti év • A cég női tulajdonosainak részaránya 52% és Vukoszávlyev Mátyásné ügyvezetői tisztséget is betölti • A projekt keretében történő műszerbeszerzések szabad vállalkozási zónában (Mórahalom) valósul meg • Iparjogvédelem: Munkavállalója, Keresztné Határvölgyi Erika több szabadalom feltalálója, a szabadalmakat a bejelentő céggel (Delta Bio 2000 Kft) kötött szerződés alapján a termelő beruházás során hasznosítja. A Delta Bio Kft és a HIperon Genetics Kft. hasznosítási szerződést kötöttek és ebből a jogügyletből gazdasági esemény is történt a támogatási kérelem benyújtását megelőző két évben, amelyet számlával, bankszámlakivonattal tud igazolni. • Nagy növekedési potenciállal rendelkező cég. nettó árbevétel 2014-ban 177 Mft, 2015-ben 357 Mft • Exportorientált vállalkozás: 2016-ban több mint 15%-a az árbevételnek exportból származott • ISO 9001 szabvány előírása szerinti minőségirányítási rendszer • A projekt keretében fejleszteni kívánt tevékenység (2110 Gyógyszeralapanyag-gyártás) az Irinyi Tervben kiemelt fejlesztendő ágazatok közé tartozik • Korábbi projektjeivel kapcsolatban szabálytalansággal nem érintett • A vállalkozás a jelen projekt keretében vezeti be az IPAR 4.0 alkalmazást. (Hungarian)
    0 references
    1, The biomolecule isolation and discharge system is suitable for isolating DNA and RNA molecules from various biological materials (cell culture, blood, tissue, tissue cultures) and can also be used for plasmid, oligonucleotide, or PCR product purification. After isolation, the system is suitable for quantitative and qualitative analysis of the isolated sample based on two independent methods (amplification and gel electrophoresis). 2,The pipette with automatic microdisk reader is suitable for compiling various enzyme reactions and for quality control of the final product. The sample dispenser is able to use different components (e.g. antibodies, enzymes or other purified proteins, substrates, buffer components) to be softwarely controlled by different volume units, with microlitre precision, into 96-well plates or different reaction tubes. 3, Molecular Biological Software Molecular Biological Software is suitable for the local and internet control of instruments and for the rapid processing of information generated by sensors incorporated into the instruments during production. With the help of molecular biological software, Hiperon Genetics Kft. the production of the product can be documented not only in real time but also retrospectively. By accessing the generated data by cloud access, the user of the product can also have password-protected access. Hiperon Genetics Ltd. is also planning to build a new building to expand its production capacity to a site owned by the company in Szeged in the framework of the present tender. Compliance with assessment criteria: • Established: In 2009, i.e. more than 5 complete financial years • The share of women’s owners in the company is 52 % and Mátyásné Vukosávlyev also holds the position of managing director • Procurement of instruments in the framework of the project is carried out in a free business zone (Mórahalom) • Industrial rights protection: Erika Keresztné, the inventor of several patents, uses the patents during the productive investment on the basis of a contract with the applicant company (Delta Bio 2000 Kft). Delta Bio Kft and HIperon Genetics Kft. have concluded a licence agreement and an economic event has also taken place from this legal transaction in the two years preceding the submission of the grant application, which it can prove by means of an invoice and a bank statement. • Company with high growth potential. net turnover 177 Mft in 2014 and 357 Mft in 2015 • Export-oriented enterprise: In 2016, more than 15 % of turnover came from exports • Quality Management System according to ISO 9001 Standard • The activity to be developed under the project (2110 Pharmaceuticals manufacturing) is one of the sectors to be developed as highlighted in the Irinyi Plan • No irregularities in relation to its previous projects • The company implements IPAR 4.0 in the framework of this project. (English)
    8 February 2022
    0 references
    Mórahalom, Csongrád-Csanád
    0 references

    Identifiers

    GINOP-1.2.1-16-2017-00954
    0 references